FY2025 Earnings Forecast for DNTH Issued By Lifesci Capital
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at Lifesci Capital boosted their FY2025 EPS estimates for Dianthus Therapeutics in a research note issued to investors on Wednesday, March 12th. Lifesci Capital analyst R. Katkhuda now anticipates that the company will earn ($2.50) per share for the year, up from their prior estimate […]
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at Lifesci Capital boosted their FY2025 EPS estimates for Dianthus Therapeutics in a research note issued to investors on Wednesday, March 12th. Lifesci Capital analyst R. Katkhuda now anticipates that the company will earn ($2.50) per share for the year, up from their prior estimate […]
